Læknablaðið - 15.09.1991, Blaðsíða 17

LÆKNABLAÐIÐ
259
HEIMILDIR
1. Salahuddin SZ, Ablashi DV, Markham PD, et al.
Isolation af a new virus. HBLV, in patients with
lymphoproliferative disorders. Science 1986; 234:
596-601,
2. Josephs SF, Salahuddin SZ, Ablashi DV, Schacter
F, Wong-Staal F, Gallo RC. Genomic analysis of the
human B-lymphotropic virus (HBLV). Science 1986;
234: 601-3.
3. Ablashi DV, Salahuddin SZ, Josephs SF, et al. HBLV
(or HHV-6) in human cell lines. Nature 1987; 329:
207.
4. Lusso P, Salahuddin SZ, Ablashi DV, Gallo RC, di
Marzo Veronese F, Markham PD. Diverse tropism of
human B-lymphotropic virus (human herpesvirus 6).
Lancet 1987; 2: 743-4.
5. Stevens JG. Human herpesviruses: a consideration of
the latent state. Microbiol Rev 1989; 53(3); 318-32.
6. Löve A. Dvergveirur. Læknablaðið 1991; 77: 241-5.
7. Yamanishi K, Okuno T, Shiraki K. et al.
Identification of human herpesvirus-6 as causal agent
for exanthem subitum. Lancet 1988; I: 1065-67.
8. Yoshiyama H, Suzuki E, Yoshida T, Kajii T,
Yamamoto N. Role of human herpesvirus 6 infection
in infants with exanthema subitum. Pediatr Infect Dis
J 1990; 9: 71-4.
9. Anderson MJ, Higgins PG, Davis LR, et al.
Experimental parvoviral infection in man. J Infect
Dis 1985; 152: 257-65.
10. Irving WL, Cunningham AL. Serological diagnosis of
infection with human herpesvirus type 6. Br Med J
1990; 300: 156-9.
11. Steeper TA, Horwitz CA, Ablashi DV, et al. The
spectrum of clinical and laboratory findings resulting
from human herpesvirus-6 (HHV-6) in patients
with mononucleosis-like illnesses not resulting from
Epstein Barr virus or cytomegalovirus. Am J Clin
Pathol 1990; 93: 776-83.
12. Dubedat S, Kappagoda N. Hepatitis due to human
herpesvirus-6. Lancet 1989; 2: 1463-4.
13. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K,
Yamanishi K. Fatal fulminant hepatitis in an infant
with human herpesvirus-6 infection. Lancet 1990:
335: 862-3.
14. Krueger GRF, Manak M, Bourgeois N, et al.
Persistent active herpes virus infection associated
with atypical polyclonal lymphoproliferation (APL)
and malignant lymphoma. Anticancer Res 1989; 9:
1457-76.
15. Josephs SF, Buchbinder A, Streicher HZ, et al.
Detection of human B-lymphotropic virus (human
herpesvirus 6) in B cell lymphoma tissues of three
patients. Leukemia 1988; 2: 132-5.
16. Ablashi DV, Josephs SF, Buchbinder A, et al. Human
B-lymphotropic virus (human herpesvirus 6). J Virol
Methods 1988; 21: 29-48.
17. Komaroff AL, Saxinger C, Buchwald D, Geiger A,
Gallo RC. A chronic »post-viral« fatigue syndrome
with neurologic features: serologic association with
human herpesvirus-6. Clin Res 1988; 36: 743A.
18. Lusso P, Ensoli B, Markham PD, et al. Productive
dual infection of human CD4+ T lymphocytes by
HIV-I and HHV-6. Nature 1989; 337: 370-3.
19. Ensoli B, Lusso P, Schachter F, et al. Human herpes
virus-6 increases HIV-1 expression in co-infected
T cells via nuclear factors binding to the HIV-1
enhancer. EMBO J 1989; 8: 3019-27.
20. Horvat RT, Wood C, Balachandran N. Transactivation
of human immunodeficiency virus promoter by
human herpesvirus 6. J Virol 1989; 63(2); 970-3.
21. Carrigan DR, Knox KK, Tapper MA. Suppression of
human immunodeficiency virus type 1 replication by
human herpesvirus-6. J Infecl Dis 1990; 162: 844-51.
22. Saxinger C, Polesky H, Eby N, et al. Antibody
reactivity with HBLV (HHV-6) in US populations.
J Virol Methods 1988; 21: 199-208.
23. Levy JA, Ferro F, Greenspan D, Lennette ET.
Frequent isolation of HHV-6 from saliva and high
seroprevalence of the virus in the population. Lancet
1990; 335: 1047-50.
24. Hamett GB, Farr TJ, Pietroboni GR, Bucens MR.
Frequent shedding of human herpesvirus 6 in saliva. J
Med Virol 1990; 30: 128-30.
25. Takahashi K, Sonoda S, Kawakami K, et al. Human
herpesvirus 6 and exanthem subitum. Lancet 1988; 1:
1463.
26. Kikuta H, Lu H, Matsumoto S. Susceptibility of
human herpesvirus 6 to acyclovir. Lancet 1989; 2:
861.